These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 22634340)
1. Association of the IL28B genotype with insulin resistance in patients with chronic hepatitis C. Stättermayer AF; Rutter K; Beinhardt S; Scherzer TM; Stadlmayr A; Hofer H; Wrba F; Steindl-Munda P; Krebs M; Datz C; Trauner M; Ferenci P J Hepatol; 2012 Sep; 57(3):492-8. PubMed ID: 22634340 [TBL] [Abstract][Full Text] [Related]
2. Insulin resistance predicts sustained virological response to treatment of chronic hepatitis C independently of the IL28b rs12979860 polymorphism. Del Campo JA; Ampuero J; Rojas L; Conde M; Rojas A; Maraver M; Millán R; García-Valdecasas M; García-Lozano JR; González-Escribano MF; Romero-Gómez M Aliment Pharmacol Ther; 2013 Jan; 37(1):74-80. PubMed ID: 23121166 [TBL] [Abstract][Full Text] [Related]
3. TM6SF2 rs58542926 is not associated with steatosis and fibrosis in large cohort of patients with genotype 1 chronic hepatitis C. Petta S; Maida M; Grimaudo S; Pipitone RM; Macaluso FS; Cabibi D; Cammà C; Di Marco V; Sferrazza S; Craxì A Liver Int; 2016 Feb; 36(2):198-204. PubMed ID: 26259026 [TBL] [Abstract][Full Text] [Related]
4. Implications of PNPLA3 polymorphism in chronic hepatitis C patients receiving peginterferon plus ribavirin. Valenti L; Aghemo A; Stättermayer AF; Maggioni P; De Nicola S; Motta BM; Rumi MG; Dongiovanni P; Ferenci P; Colombo M; Fargion S Aliment Pharmacol Ther; 2012 Jun; 35(12):1434-42. PubMed ID: 22530607 [TBL] [Abstract][Full Text] [Related]
5. The rs738409 polymorphism of the PNPLA3 gene is associated with hepatic steatosis and fibrosis in Brazilian patients with chronic hepatitis C. Manchiero C; Nunes AKDS; Magri MC; Dantas BP; Mazza CC; Barone AA; Tengan FM BMC Infect Dis; 2017 Dec; 17(1):780. PubMed ID: 29258449 [TBL] [Abstract][Full Text] [Related]
6. IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease. Petta S; Grimaudo S; Cammà C; Cabibi D; Di Marco V; Licata G; Pipitone RM; Craxì A J Hepatol; 2012 Jun; 56(6):1356-62. PubMed ID: 22314430 [TBL] [Abstract][Full Text] [Related]
7. PNPLA3 rs738409 causes steatosis according to viral & IL28B genotypes in hepatitis C. Ampuero J; Del Campo JA; Rojas L; García-Lozano JR; Solá R; Andrade R; Pons JA; Navarro JM; Calleja JL; Buti M; González-Escribano MF; Forns X; Diago M; García-Samaniego J; Romero-Gómez M Ann Hepatol; 2014; 13(4):356-63. PubMed ID: 24927606 [TBL] [Abstract][Full Text] [Related]
8. Effects of IL28B rs12979860 CC genotype on metabolic profile and sustained virologic response in patients with genotype 1 chronic hepatitis C. Petta S; Rosso C; Leung R; Abate ML; Booth D; Salomone F; Gambino R; Rizzetto M; Caviglia P; Smedile A; Grimaudo S; Cammà C; Craxì A; George J; Bugianesi E Clin Gastroenterol Hepatol; 2013 Mar; 11(3):311-7.e1. PubMed ID: 23220171 [TBL] [Abstract][Full Text] [Related]
9. Role of FDFT1 polymorphism for fibrosis progression in patients with chronic hepatitis C. Stättermayer AF; Rutter K; Beinhardt S; Wrba F; Scherzer TM; Strasser M; Hofer H; Steindl-Munda P; Trauner M; Ferenci P Liver Int; 2014 Mar; 34(3):388-95. PubMed ID: 23870067 [TBL] [Abstract][Full Text] [Related]
10. Insulin resistance undermines the advantages of IL28B polymorphism in the pegylated interferon alpha-2b and ribavirin treatment of chronic hepatitis C patients with genotype 1. Ogawa E; Furusyo N; Murata M; Ikezaki H; Ihara T; Hayashi T; Toyoda K; Taniai H; Okada K; Kainuma M; Hayashi J J Hepatol; 2012 Sep; 57(3):534-40. PubMed ID: 22613000 [TBL] [Abstract][Full Text] [Related]
11. Association between PNPLA3[G]/I148M variant, steatosis and fibrosis stage in hepatitis C virus - genetic matters. Crisan D; Grigorescu M; Crisan N; Craciun R; Lupsor M; Radu C; Grigorescu MD; Suciu A; Epure F; Avram L; Leach N J Physiol Pharmacol; 2019 Aug; 70(4):. PubMed ID: 31642820 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-28B rs12979860 C allele: Protective against advanced fibrosis in chronic hepatitis C genotype 1 infection. Kitson MT; George J; Dore GJ; Leung R; Button P; McCaughan GW; Grawford DH; Siebert W; Weltman MD; Cheng WS; Roberts SK J Gastroenterol Hepatol; 2014; 29(7):1458-62. PubMed ID: 25587616 [TBL] [Abstract][Full Text] [Related]
13. Interleukin 28B genotype and insulin resistance in chronic hepatitis C patients. Degasperi E; Valenti L; Aghemo A; De Francesco R; Rumi M; Soffredini R; Donnici L; Cheroni C; Fargion S; Zanoni V; Orsi E; Colombo M Antivir Ther; 2014; 19(8):747-53. PubMed ID: 24523350 [TBL] [Abstract][Full Text] [Related]
14. Impact of comorbid hepatic steatosis on treatment of chronic hepatitis C in Japanese patients and the relationship with genetic polymorphism of IL28B, PNPLA3 and LDL receptor. Moritou Y; Ikeda F; Iwasaki Y; Baba N; Takaguchi K; Senoh T; Nagano T; Takeuchi Y; Yasunaka T; Ohnishi H; Miyake Y; Takaki A; Nouso K; Yamamoto K Acta Med Okayama; 2014; 68(1):17-22. PubMed ID: 24553484 [TBL] [Abstract][Full Text] [Related]
15. Genetic Polymorphisms of IL28B and PNPLA3 Are Predictive for HCV Related Rapid Fibrosis Progression and Identify Patients Who Require Urgent Antiviral Treatment with New Regimens. Tamaki N; Kurosaki M; Higuchi M; Takada H; Nakakuki N; Yasui Y; Suzuki S; Tsuchiya K; Nakanishi H; Itakura J; Takahashi Y; Ogawa S; Tanaka Y; Asahina Y; Izumi N PLoS One; 2015; 10(9):e0137351. PubMed ID: 26352693 [TBL] [Abstract][Full Text] [Related]
16. Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C. Trépo E; Pradat P; Potthoff A; Momozawa Y; Quertinmont E; Gustot T; Lemmers A; Berthillon P; Amininejad L; Chevallier M; Schlué J; Kreipe H; Devière J; Manns M; Trépo C; Sninsky J; Wedemeyer H; Franchimont D; Moreno C Hepatology; 2011 Jul; 54(1):60-9. PubMed ID: 21488075 [TBL] [Abstract][Full Text] [Related]
17. The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection. Scheiner B; Mandorfer M; Schwabl P; Payer BA; Bucsics T; Bota S; Aichelburg MC; Grabmeier-Pfistershammer K; Stättermayer A; Ferenci P; Trauner M; Peck-Radosavljevic M; Reiberger T PLoS One; 2015; 10(11):e0143429. PubMed ID: 26599080 [TBL] [Abstract][Full Text] [Related]
18. The association of genetic variants with hepatic steatosis in patients with genotype 1 chronic hepatitis C infection. Clark PJ; Thompson AJ; Zhu Q; Vock DM; Zhu M; Patel K; Harrison SA; Naggie S; Ge D; Tillmann HL; Urban TJ; Shianna K; Fellay J; Goodman Z; Noviello S; Pedicone LD; Afdhal N; Sulkowski M; Albrecht JK; Goldstein DB; McHutchison JG; Muir AJ Dig Dis Sci; 2012 Aug; 57(8):2213-21. PubMed ID: 22543885 [TBL] [Abstract][Full Text] [Related]
19. Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C. Valenti L; Rumi M; Galmozzi E; Aghemo A; Del Menico B; De Nicola S; Dongiovanni P; Maggioni M; Fracanzani AL; Rametta R; Colombo M; Fargion S Hepatology; 2011 Mar; 53(3):791-9. PubMed ID: 21319195 [TBL] [Abstract][Full Text] [Related]
20. Association between CXCL10 and DPP4 Gene Polymorphisms and a Complementary Role for Unfavorable IL28B Genotype in Prediction of Treatment Response in Thai Patients with Chronic Hepatitis C Virus Infection. Thanapirom K; Suksawatamnuay S; Sukeepaisarnjaroen W; Tangkijvanich P; Treeprasertsuk S; Thaimai P; Wasitthankasem R; Poovorawan Y; Komolmit P PLoS One; 2015; 10(9):e0137365. PubMed ID: 26339796 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]